ARTICLE | Company News
SK Biopharmaceuticals, Shanghai Medicilon Inc. deal
November 7, 2011 8:00 AM UTC
The companies partnered to develop SK's SKL-PSY to treat depression and bipolar disorder. The small molecule targeting serotonergic receptors is in preclinical testing for the indications, which the ...